-------如果这里没有任何信息，不是真没有，是我们懒！请复制书名上amazon搜索书籍信息。-------
###-Book Description Begin-###
by Rajeev Chawla (Author), Shalini Jaggi (Author)
Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated in the writing of this book to bring to the readers an updated overview of this novel drug class. An in depth search of literature on all topics traces how the SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes, with promising data emerging on their use in type 1 diabetes as well. The book has been written in simple language and a standard pattern with a crisp introduction of the topic to brief the reader on what to expect in the text, followed at the end by a short conclusion that sums up the text for quick reference of its readers The book is aimed at all health care practitioners, physicians and medical students/postgraduates with an avid interest in the latest advances in the evolution of this drug class for diabetes management. Written by experts in the field of diabetes with a vast clinical experience with these agents.
Publisher : Jaypee Brothers Medical Publishers (30 Oct. 2019)
Language : English
Paperback : 114 pages
ISBN-10 : 9352706803
ISBN-13 : 978-9352706808
